NCT02115282
Clinical Trial Information
Trial Number: NCT02115282 (ClinicalTrials.gov)
Disease Type:
- Breast Neoplasm - Breast Cancer (Invasive)
- Breast Neoplasm - Miscellaneous
Trial Title:
A Randomized Phase III Trial of Endocrine Therapy Plus Entinostat/Placebo in Patients With Hormone Receptor-Positive Advanced Breast Cancer
Study ID:
E2112
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
| Title | Description |
|---|---|
| NCT02115282-D2 | There are two submissions for PMID 34357781. This dataset, NCT02115282-D2, contains toxicity data. Dataset NCT02115282-D1 contains baseline, treatment, and efficacy data |
| NCT02115282-D1 | There are two submissions for PMID 34357781. This dataset, NCT02115282-D1, contains baseline, treatment, and efficacy data. Dataset NCT02115282-D2 contains toxicity data. |
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®